Skip to menu Skip to content Skip to footer

2019

Conference Publication

Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis

Goyal, Vikas, Grimwood, Keith, Ware, Rob, Brynes, Catherine, Morris, Peter, Masters, Ian, Mccallum, Gabrielle, Binks, Michael, Smith-Vaughan, Heidi, O'Grady, Kerry-Ann, Champion, Anita, Buntain, Helen, Schultz, Andre, Chatfield, Mark, Torzillo, Paul and Chang, Anne (2019). Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis. European-Respiratory-Society (ERS) International Congress, Madrid, Spain, 28 September - 2 October 2019 . Lausanne, Switzerland: European Respiratory Society. doi: 10.1183/13993003.congress-2019.RCT5101

Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis

2018

Conference Publication

Assessing the suitability of fractional exhaled nitric oxide (feno) cut-off ranges for Aboriginal and/or Torres Strait Islander children and young adults

Blake, T., Chang, A., Chatfield, M., Petsky, H. and Mcelrea, M. (2018). Assessing the suitability of fractional exhaled nitric oxide (feno) cut-off ranges for Aboriginal and/or Torres Strait Islander children and young adults. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Adelaide, SA, Australia, 23–27 March 2018. Richmond, VIC, Australia: John Wiley & Sons.

Assessing the suitability of fractional exhaled nitric oxide (feno) cut-off ranges for Aboriginal and/or Torres Strait Islander children and young adults

2018

Conference Publication

Self-reported and medical chart histories of Australian Aboriginal and Torres Strait Islander (Indigenous) children and young adults

Blake, Tamara, Chatfield, Mark, Chang, Anne, Petsky, Helen and Mcelrea, Margaret (2018). Self-reported and medical chart histories of Australian Aboriginal and Torres Strait Islander (Indigenous) children and young adults. 28th International Congress of the European-Respiratory-Society (ERS), Paris France, 15-19 September 2018. Lausanne, Switzerland: European Respiratory Society. doi: 10.1183/13993003.congress-2018.PA4682

Self-reported and medical chart histories of Australian Aboriginal and Torres Strait Islander (Indigenous) children and young adults

2018

Conference Publication

Spirometry reference values for Australian Aboriginal and Torres Strait Islander (Indigenous) children and young adults

Blake, Tamara, Chatfield, Mark, Chang, Anne, Petsky, Helen and Mcelrea, Margaret (2018). Spirometry reference values for Australian Aboriginal and Torres Strait Islander (Indigenous) children and young adults. 28th International Congress of the European-Respiratory-Society (ERS), Paris France, 15-19 September 2018. Lausanne, Switzerland: European Respiratory Society. doi: 10.1183/13993003.congress-2018.OA3777

Spirometry reference values for Australian Aboriginal and Torres Strait Islander (Indigenous) children and young adults

2018

Conference Publication

Epidemiological analysis of infective endocarditis in a major tertiary centre: a comparison between intravenous drug users and non-intravenous drug users over a six-year period

Yoon, J., Ramnarain, J., Sivabalan, P., Simos, P., Chatfield, M. and Runnegar, N. (2018). Epidemiological analysis of infective endocarditis in a major tertiary centre: a comparison between intravenous drug users and non-intravenous drug users over a six-year period. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.607

Epidemiological analysis of infective endocarditis in a major tertiary centre: a comparison between intravenous drug users and non-intravenous drug users over a six-year period

2018

Conference Publication

Exploring the impact of recipient age with kidney donor risk index and estimated glomerular filtration rate at one year following kidney transplant

Chan, S., Chatfield, M. and Baboolal, K. (2018). Exploring the impact of recipient age with kidney donor risk index and estimated glomerular filtration rate at one year following kidney transplant. American Transplant Congress, Seattle, WA, United States, 2-6 June, 2018. Hoboken, NJ, United States: Wiley-Blackwell Publishing. doi: 10.1111/ajt.14918

Exploring the impact of recipient age with kidney donor risk index and estimated glomerular filtration rate at one year following kidney transplant

2018

Conference Publication

Telehealth residential care medication reviews to enable collaboration of pharmacists and geriatricians

Hanjani, L. S., Peel, N., Freeman, C., Caffery, L., Chatfield, M., Hubbard, R. and Gray, L. (2018). Telehealth residential care medication reviews to enable collaboration of pharmacists and geriatricians. The Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting 2018, Cutting Edge: Optimising the Journey for Older Surgical Patients, Sydney, Australia, 27-29 June 2018. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Telehealth residential care medication reviews to enable collaboration of pharmacists and geriatricians

2017

Conference Publication

Early postnatal impairment of renal function in indigenous infants born preterm

Sutherland, M. R., Ryan, D., Davison, B., Chatfield, M., Diwakarla, S., Hoy, W. E., Singh, G. and Black, M. J. (2017). Early postnatal impairment of renal function in indigenous infants born preterm. 53rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Darwin, Northern Territory, 4-6 September 2017. Richmond, VIC, Australia: Wiley-Blackwell.

Early postnatal impairment of renal function in indigenous infants born preterm

2014

Conference Publication

Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC)

Mahon, Kate Lynette, Qu, Wenjia, Devaney, James, Paul, Cheryl, Castillo, Lesley, Wykes, Richard, Chatfield, Mark D., Boyer, Michael J., Stockler, Martin R., Marx, Gavin M., Gurney, Howard, Gowda, Girish Mallesara Hiriyanna, Molloy, Peter, Horvath, Lisa and Clark, Susan J. (2014). Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC). Genitourinary Cancers Symposium, San Francisco Ca, Jan 30-Feb 01, 2014. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2014.32.4_suppl.11

Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC)

2013

Conference Publication

The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)

Mahon, Kate, Chatfield, Mark, Breit, Samuel, Brown, David, Molloy, Mark, Marx, Gavin, Pavlakis, Nick, Boyer, Michael, Stockler, Martin and Horvath, Lisa (2013). The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC). HOBOKEN: WILEY-BLACKWELL.

The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)

2013

Conference Publication

The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)

Horvath, Lisa, Chatfield, Mark D., Lee-Ng, Michelle, Lin, Hui-Ming, Castillo, Lesley, Breit, Samuel N., Brown, David A., Molloy, Mark P., Marx, Gavin M., Pavlakis, Nick, Boyer, Michael J., Stockier, Martin R., Wykes, Richard, Henshall, Susan M. and Mahon, Kate Lynette (2013). The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)

2013

Conference Publication

A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial

Mccallum, G., Morris, P. S., Chatfield, M. D., Maclennan, C., White, A., Versteegh, L., Wilson, C., Jacobsen, N. and Chang, A. B. (2013). A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12046

A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial

2012

Conference Publication

Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC)

Sjoquist, Katrin Marie, Lee, Chee, Lord, Sally, Chatfield, Mark D., Friedlander, Michael, Simes, John and Marschner, Ian (2012). Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC)

2012

Conference Publication

EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901)

Davis, Ian D., Gebski, Val, Chatfield, Mark D., Grimison, Peter S., Kannourakis, George, Boland, Amy L., Thompson, Jennifer and Stockler, Martin R. (2012). EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901)

2012

Conference Publication

Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials

Grimison, Peter S., Chatfield, Mark D., Mazhar, Danish, Toner, Guy C., Chester, John D., Stockler, Martin R., Stark, Daniel P., Thomson, Damien B., Shamash, Jonathan, Friedlander, Michael, White, Jeff, Gebski, Val, Wason, James, Boland, Amy L., Rimmer, Yvonne L., McDonald, Angus, Gurney, Howard, Rosenthal, Mark, Singhal, Nimit and Williams, Michael V. (2012). Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology.

Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials

2011

Conference Publication

MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)

Yip, Po Yee, Cooper, Wendy, Mahar, Annabelle, Kench, James, Kohonen-Corish, Maija R. J., Chatfield, Mark, Boulghourjian, Alice, Kennedy, Catherine W., Mccaughan, Brian, Boyer, Michael and Horvath, Lisa (2011). MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)

2011

Conference Publication

PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD

Kao, Steven C., Clarke, Stephen, Chatfield, Mark, Corte, Peter, Clarke, Christopher, Vardy, Janette and Van Zandwijk, Nico (2011). PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD

2011

Conference Publication

CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP)

Kao, Steven C., Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola, Yan, Tristan, Vardy, Janette, Clarke, Stephen, Van Zandwijk, Nico and Mccaughan, Brian (2011). CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP)

2008

Conference Publication

Designing an algorithm to calculate intestinal iron availability

Rickard, Anna P., Chatfield, Mark D., Stephen, Alison M. and Powell, Jonathan J. (2008). Designing an algorithm to calculate intestinal iron availability. 10th International Symposium on Metal Ions in Biology and Medicine, Bastia France, May 19-22, 2008. MONTROUGE: JOHN LIBBEY EUROTEXT.

Designing an algorithm to calculate intestinal iron availability